HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.

AbstractPURPOSE:
Image quality (IQ) of PET in voluminous body regions can be limited, which impairs the assessment of small metastatic lesions. Time-of-flight (TOF) reconstruction algorithm may deliver an increase of spatial resolution. The purpose of this study was to evaluate the impact of TOF on IQ, lesion detection rate, lesion volume (V) and SUVmax in F choline PET/CT of prostate cancer patients with biochemical recurrence compared to standard PET/CT reconstruction (standard).
PATIENTS AND MATERIALS:
During a period of 9 months, 32 patients with prostate cancer (mean [SD] age, 71 [7.8] years) and biochemical recurrence were included in this prospective institutional review board-approved study. Each patient underwent a state-of-the-art 3-dimensional F choline PET/CT. A total of 76 lesions were assessed by 2 board-certified nuclear medicine physicians and a third-year resident. Lesion volume and SUVmax of local recurrence, lymph nodes, and organ metastases were compared between TOF and standard. Image quality and lesion demarcation were rated according to a 5-point Likert-type scale. Interobserver agreement was assessed.
RESULTS:
Eight additional lesions were detected using TOF (SUVmax, 3.64 [0.95]; V, 0.58 cm [0.50]). Image quality was reduced (IQ standard, 1.28; TOF, 1.77; P < 0.01) in calculated TOF images, although quality of lesion demarcation was improved (lesion demarcation: standard, 1.66; TOF, 1.26; P < 0.01). SUVmax was significantly increased in TOF images (SUVmax standard, 6.9 [4.1]; TOF, 8.1 [4.1]; P < 0.01), whereas V did not show significant differences (V standard, 5.3 [10.4] cm; TOF, 5.4 [10.3] cm; P = 0.41). Interobserver agreement was good for combined ratings (1 + 2 and 3 + 4).
CONCLUSIONS:
Application of TOF seems to be of additional value to detect small metastatic lesions in patients with prostate cancer and biochemical recurrence, which may have further clinical implications for secondary treatment.
AuthorsDaniel Hausmann, Leonardo K Bittencourt, Ulrike I Attenberger, Metin Sertdemir, Anja Weidner, Karen A Büsing, Joachim Brade, Frederik Wenz, Stefan O Schoenberg, Dietmar J Dinter
JournalClinical nuclear medicine (Clin Nucl Med) Vol. 39 Issue 3 Pg. e197-201 (Mar 2014) ISSN: 1536-0229 [Electronic] United States
PMID24092230 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • fluoromethylcholine
  • Choline
Topics
  • Algorithms
  • Choline (analogs & derivatives)
  • Humans
  • Image Processing, Computer-Assisted
  • Male
  • Multimodal Imaging
  • Neoplasm Recurrence, Local (diagnostic imaging, pathology)
  • Observer Variation
  • Positron-Emission Tomography
  • Prostatic Neoplasms (diagnostic imaging, pathology)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: